3Libby P,Ridker PM,Maseri A.Inflammation and atherosclerosis[J].Circulation,2002,105:1135-1143.
4Wilson AM,Ryan MC,Boyle AJ.Tbe novel role of C-reactive protein in cardiovascular disease:risk marker or pathologen[J].Int J Cardiol,2006,106(3):291-297.
5Burker AP,Tracy BP,Kolodgie F,et al.Elevated C-reactive protein values and atherosclerosis in sudden coronary death:association with different pathologies[J].Circulation,2002,105:2019-2023.
8Cipollone F,Ferri C,Desideri G,et al.Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty[J].Circulation,2003,108(22):2776-2782.
9Kai H,Ikeda H,Yasukawa H,et al.Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes[J].J Am Coll Cardiol,1998,32(2):368-372.
10Nomoto K,Oguchi S,Watanabe I,et al.Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein,matrix metalloproteinase-9 and soluble vascular-cell adhesion molecule-1[J].J Cardiol,2003,42(5):201-206.
2Fukuda D,Shimada K,Tanaka A,et al.Comparison oflevels of serum matrix metalloproteinase-9 in patients w ithacute myocardial infarction versus unstable angina pectorisversus stable angina pectoris[J] .American Journal ofCardiology,2006,97 (2):175-180.
3Funayama H,Ishikawa S,Yasu T,et al.Matrix Metallo-proteinase-9 may be a new biomarker for coronary plaquerupture in patients w ith acute myocardial infarction[J] .Circulation,2006,114(18):783.
4Hadler-Olsen E,Fadnes B,Sylte I,et al.Regulation of matrix metalloproteinase activity in health and disease[J] .FEBS Journal,2011,278(1):28-45.
5Mandrekar J N.Receiver operating characteristic curve in diagnostic test assessment[J] .Journal of Thoracic On- cology,2010,5(9):1315-1316.
6Gach O,Legrand V,Biessaux Y,et al.Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients w ith stable angina pectoris[J] .American Journal of Cardiology,2007,99(1):31-35.
